Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of Divis Laboratories Ltd.



DIVISLAB
Divis Laboratories Ltd.

Rs. 3537.90
06-Jun-2023

5 Yr Performance

1 Yr Performance

Valuation

Quarterly

Earnings Yield



Analysis


Upgrade to Professional Membership

Quarterly Revenue, Net Income and Adjusted Share Price



Upgrade to Professional Membership

Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.